AU6149896A - Flexible source wire for localized internal irradiation of tissue - Google Patents

Flexible source wire for localized internal irradiation of tissue

Info

Publication number
AU6149896A
AU6149896A AU61498/96A AU6149896A AU6149896A AU 6149896 A AU6149896 A AU 6149896A AU 61498/96 A AU61498/96 A AU 61498/96A AU 6149896 A AU6149896 A AU 6149896A AU 6149896 A AU6149896 A AU 6149896A
Authority
AU
Australia
Prior art keywords
wire
tube
backbone
radioactive
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU61498/96A
Other versions
AU696822B2 (en
Inventor
Samuel F. Liprie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interventional Therapies LLC
Original Assignee
Interventional Therapies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23907457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU6149896(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Interventional Therapies LLC filed Critical Interventional Therapies LLC
Publication of AU6149896A publication Critical patent/AU6149896A/en
Assigned to ANGIORAD, L.L.C. reassignment ANGIORAD, L.L.C. Alteration of Name(s) of Applicant(s) under S113 Assignors: LIPRIE, SAMUEL F.
Application granted granted Critical
Publication of AU696822B2 publication Critical patent/AU696822B2/en
Assigned to INTERVENTIONAL THERAPIES, L.L.C. reassignment INTERVENTIONAL THERAPIES, L.L.C. Alteration of Name(s) in Register under S187 Assignors: ANGIORAD, L.L.C.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21FPROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
    • G21F5/00Transportable or portable shielded containers
    • G21F5/015Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation units; Radioisotope containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1002Intraluminal radiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019Sources therefor
    • A61N2005/1025Wires
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49826Assembling or joining
    • Y10T29/49888Subsequently coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiation-Therapy Devices (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Eye Examination Apparatus (AREA)

Description

FLEXIBLE SOURCE WIRE FOR LOCALIZED INTERNAL IRRADIATION OF TISSUE
REFERENCE TO RELATED PATENT APPLICATIONS
The present application is a conύnuation-in-part of U.S. application Serial No. 08/257,045 filed June S, 1994 and entitled "Flexible Source Wire for Radiation Treatment of Diseases," the entire contents and disclosure of which are hereby specifically incorporated by reference.
FIELD OF THE INVENTION
The present invention relates generally to radioactive source wires used to irradiate body tissue in the treatment of disease. More particularly, the present invention relates to the use of an elongated radioactive source wire with increased flexibility for the localized delivery of radiation to diseased tissue.
BACKGROUND OF THE INVENTION
Radiation is used to treat cancer and other diseases of the body. Radiation has long been proven to destroy fast multiplying cells (e.g., cancer) in hopes of destroying or preventing the spread of the disease. Brachytherapy, which is the treatment of cancer at close distances, is one example of the use of radiation for treating diseases of the body. During brachytherapy, a radioactive source or sources are positioned in the area needing treatment- Depending on the shape, size and delivery means of the radioactive sources, the sources are either kept permanently in the body or removed after a specific amount of time. Since permanent implants are tiny seeds approximately 3mm long and 0.5mm wide, the use of these seeds do not relate to the present invention. Consequently, the focus of this application will be on the field of temporary implants. The term temporary implants describes the procedure of maneuvering a radioactive source or sources to the treatment site utilizing a transport catheter or tube which has been previously placed in the vicinity of this treatment site. Alternatively, the transport catheter and temporary implant can simultaneously be maneuvered to the treatment site. In either situation, after a specified period of time, these sources and the transport catheter or tube are removed from the body. Since the radioactive source or sources may encounter a tortuous path in various arteries, veins, ducts, or the like inside the body to reach the treatment site, the radioactive source is usually attached by some device to a flexible drive member. This source and the drive member may be used many times, and, therefore must be able to withstand the many bends it encounters when it is maneuvered to the treatment site or removed therefrom, without breaking. There are several devices on the market in which radioactive sources are attached to flexible drive members. Each of these devices is constructed in a different fashion and each has its limitations. Examples of these prior art devices are described in U.S. Patents 4,819,618 and 5,141,486, both issued to Liprie as well as U.S. Patent 4, 861,520 issued to van't Hooft The two Liprie patents describe a radioactive element which is attached to a drive member by means of a junction welded to the drive cable. The patent to van't Hooft describes an apparatus which attaches radioactive sources to a drive cable by means of a stiff capsule welded into the end of the cable. Since the most resistive portion to flection of any flexible material, such as a cable, tube, or wire is the segment closest to the end, to job a capsule which is stiffer than this material and welded onto its end would only add to the resistance to bending and would adversely effect maneuvering the material through the body.
U.S. Patent 5,084,002 issued to Liprie describes an ultra-thin high dose iridium source included within an oversized hole drilled inside the end of a solid platinum wire. Drilling a hole into a thin wire is very difficult since the maximum depth the hole can be drilled is equal to approximately seven times the outside diameter of the wire. To drill a hole deeper than this is extremely difficult due to the drifting of the drill as it burrows the hole. This drifting can lead to a thinning of the cavity walls which greatly increases the chances of breakage. This breakage is often disastrous, resulting in unwarranted radiation exposure. A larger outside diameter wire will be needed to compensate for the drifting and still allow the walls of the cavity to be thick enough to withstand stress. Unfortunately, this larger diameter wire might be too large to fit into many constricted areas of the body. As described in Liprie '002 one can drill a cavity inside a solid wire, if one starts with an oversize wire and an oversize hole and then the whole assembly is drawn down to the desire diameter of the wire. However, whenever a wire is drawn down, the assembly containing the cavity elongates and the precise positioning of the radioactive core inside the assembly can become very difficult Additionally, this larger diameter wire would result in less flexibility and may not be able to be maneuvered to the treatment site.
Finally, U.S. Patent 5.282,781 issued to Liprie employs tube, a backbone wire, a pure iridium core and a plug and draws down the entire assembly to form a tight seal between the housing material and the backbone wire and the plug. Without this drawing down of the housing onto the backbone wire, radioactive flakes from the core would migrate throughout the inside of the assembly wire, resulting in unwanted contamination. This "drawing down" step would increase the costs and difficulty of manufacturing the source wire. Furthermore, any "drawing down" step as described in U.S. Patent No. 5,084,002 and U.S. Patent No. 5,282,781 would not work on a memory resistant alloy. As soon as a memory resistant alloy had been drawn through a die, the alloy would resume its original shape. If the memory resistant alloy was drawn beyond the threshold of its elasticity, then the memory resistant properties of the alloy would be destroyed.
Thus, there exists a need for a radioactive source wire that has an extremely small diameter and is flexible, yet has sufficient tensile strength to traverse a tortuous route of bends and turns without breaking. It is an object of the present invention to provide a small diameter source wire that is extremely flexible and will allow the source to travel to the site of treatment without binding. It is another object of the present invention to provide a source wire that is strong enough to withstand the stresses placed upon the source, as it is maneuvered to and from the site of treatment within the patient, without breaking.
Yet another object of the present invention is to provide an improved source wire design that includes a mechanism for relieving some of the stress encountered by the metal housing tube of the source wire as it is maneuvered to the treatment site.
Still yet another object of the present invention is to provide an improved source wire that exhibits little or no memory retention when bent.
An additional object of the present invention is to provide for improved methods of manufacturing source wires that would decrease the costs and difficulty in manufacturing source wires without sacrificing the quality of the manufactured source wire.
SUMMARY OF THE INVENTION
These and other deficiencies of the prior art are addressed by the present invention which is directed to a flexible source wire for the radiation treatment of disease in which the source wire contains a radioactive core and is easily maneuvered to the site of treatment through various conduits in the body.
A flexible source wire is provided containing a radioactive source that is capable of maneuvering through a tortuous narrow passage to a treatment site within the body. This source wire includes a thin flexible housing tube, housing therein a flexible backbone wire, wherein both the tube and the wire are constructed from a material exhibiting little or no memory retention when bent. A radioactive core is provided in the proximal end (i.e., the treatment end) of the thin flexible housing tube and abuts the proximal end of the backbone wire. Both ends of the source wire are sealed and at least the proximal end of the source wire is rounded to allow ease of movement as it travels through the bends and turns in the body.
The flexible source wire described herein may have a backbone wire that is tapered at the end closest to the radioactive core. The tapered end of the backbone wire teπninates next to the radioactive core in a rounded area shaped like a ball. The radioactive core, positioned within the housing tube, may exist openly within the housing tube or may be localized in an open-ended capsule or may be encapsulated by a thin-walled, flexible material or coating that allows the passage of neutrons. One advantage of the present invention is that it provides a smaller diameter source wire than is currently available. Another feature and advantage of the present invention is that the source wire has a sufficient tensile strength and flexibility to withstand the stresses encountered when the source wire is maneuvered to the site of treatment.
Yet another feature and advantage of the present invention is that it provides a novel mechanism for relieving some of the stress encountered by the metal housing tube as the source wire is maneuvered to the treatment site.
Still yet another feature and advantage of the present invention is that the source wire is made of a material that can undergo a 1% strain with less than a 1% alteration in its original conformation. A further feature and advantage of the present invention is that it provides improved methods of manufacturing source wires that will save the manufacturer time and money.
Additional features and advantages of the invention will be described hereinafter which form the subject of the claims of the invention. It should be appreciated by those skilled in the art that the conception and the specific embodiment disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the present invention. It should also be realized by those skilled in the art that such equivalent constructions do not depart from the spirit and scope of the invention as set forth in the claims of the invention.
B TF.F DESCRIPTION OF THE DRAWINGS
For a more complete understanding of the present invention, and the advantages thereof, reference is now made to the following descriptions taken in conjunction with the accompanying drawings, in which: FIGURE 1 is a partial cross-section of one embodiment of a source wire showing a backbone wire and a radioactive core enclosed within a flexible housing tube;
FIGURE 2 is a partial cross-section of another embodiment of a source wire showing a radioactive core enclosed in a capsule within the flexible housing tube;
FIGURE 3 is a partial cross-section of another embodiment of the present invention having a radioactive core in an open-ended capsule within a flexible housing tube;
FIGURE 4A is a partial cross-section of another embodiment of the present invention having a tapered backbone wire with a rounded area on the proximal tip of the backbone wire;
FIGURE 4B shows the embodiment illustrated in FIGURE 4A where the backbone wire has altered its shape in response to stress; FIGURE 4C shows an embodiment having the tapered backbone wire illustrated in
FIGURE 4A but where the radioactive core is placed directly into the housing tube rather than in an open-ended capsule;
FIGURES 5A through C show a diagrammatic view of a source wire and what happens when the flexible housing tube breaks and the backbone wire is not attached to the inner surface of the housing tube; FIGURES 5D and E show a diagrammatic view of a source wire, with and without a break in the housing tube, where the backbone wire is attached to the inner surface of the housing tube;
FIGURE 6 shows a partial cross-section of a source wire positioned in a heat sink before its proximal end is sealed; and
FIGURE 7 shows a paπial cross-section of a source wire having a backbone, comprised of a number of balls linked together by a thin wire, and a radioactive core coated with a neutron permeable material within a flexible housing tube.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention relates to the design and manufacture of improved source wires for delivering radioactivity to a site of treatment within the human body. The invention relates to a novel source wire design that provides improved source wire flexibility and strength such that the improved source wire can survive the stress encountered when it is subjected to the manipulations necessary to maneuver the source wire to and from an internal treatment site for the localized delivery of radiation to diseased tissue. The present invention may be used to treat cancer, stenosis, or other diseases of the body. The use of the present invention in the treatment of stenosis is described in co-pending U.S. patent application entitled "Method and Apparatus for Treating Stenosis," Serial No. 08/220,681, and is hereby incorporated by reference herein.
Referring now to the drawings, and initially to FIGURE 1, it is emphasized that the Figures, or drawings, are not intended to be to scale. For example, purely for the sake of greater clarity in the drawings, wall thickness and spacings are not dimensioned as they actually exist in the assembled embodiments. Furthermore, the lengths of the backbone wire and the radioactive core are illustrated out of proportion to how they actually exist, purely for the sake of clarity.
FIGURE 1 illustrates a first embodiment of a source wire 10. Among the components of the source wire 10 is a thin, elongated, flexible metal housing tube 120. Since this housing tube 120 is used to maneuver the radioactive core to a remote treatment site, the length of the tube must be adequate to reach the treatment site when the source wire 10 is inserted through a catheter implanted in a patient's body for that purpose. Typically, tube 120 will have a length of at least 100 cm and may extend for a much greater distance. Additionally, the outside diameter of tube 120 will range from about 0.012" to about 0.018" and is preferably about 0.014". Tube 120 has thin walls, with a wall thickness ranging from about 0.0020" to about 0.0035" and is preferably about 0.0025". The internal diameter of the housing tube ranges from about 0.008" to about 0.014" and is preferably about 0.0093".
Selecting the size of the metal housing tube 120 requires that one balance the increased trauma to the tissue through which source wire 10 will pass, with the increase in tensile strength and elongation of larger tubing. The tubing to be used should be as small as practical and still have the tensile strength, flexibility, and elongation properties necessary to withstand the pressures put upon the source wire while it is maneuvered throughout the body.
Preferably, housing tube 120 is constructed from a material that can accept up to a 1% strain with less than a 1% alteration in its original shape (i.e., a material that exhibits little or no memory retention when bent). Most metals such as stainless steel will incur a permanent alteration in its original shape when subjected to as little as a 0.1% strain. An example of a material that exhibits little or no memory retention when bent is Tinel Alloy BB, a titanium/nickel alloy, manufactured by Raychem Corporation, Menlo Park, California. Another commercially available alloy with similar properties is Nitinol® manufactured by Shape Memory Alloys, Sunnyvale, California. Tinel Alloy BB, and other such nickel/titantium alloys, are comprised of about equal quantities of nickel and titantium, such as an alloy composed of about 55% nickel and about 45% titantium. Tube 120 has two ends, one of which will ultimately constitute the proximal end 140 and the other the distal end 150 of source wire 10. The proximal end 140 should be rounded to facilitate the movement of source wire 10 through the bends and turns of the vasculature, or other treatment sites. Another component of source wire 10 is a flexible backbone wire 130 which has a diameter slightly less than the inner diameter of housing tube 120, and is preferably about 0.0085" in diameter. Since the backbone wire 130 has a smaller diameter than the inner diameter of the housing tube 120, a small gap 175 will exist between the outer surface of the backbone wire 130 and the inner surface of the housing tube 120. Backbone wire 130 is positioned within the lumen of metal tube 120 from the distal end 150 of tube 120 and extending virtually the entire length of the tube except for a portion of tube 120 at the proximal end which will accommodate the radioactive core 160. Backbone wire 130 will generally be secured to the distal end 150 of housing tube 120 by weld 165, or some other means of attachment such as gluing. In addition, backbone wire 130 may be affixed to the inner surface of housing tube 120 at a variety of attachment sites 168.
An important function of backbone wire 130 is to enhance the flexibility of source wire 10. The outer metal housing tube 120 has a certain degree of flexibility, but in the absence of inner support would tend to bend or buckle and may even collapse when transversing tight turns through a catheter. That tendency is prevented by the presence of the internal backbone wire 130. Thus, the backbone wire 130, like the housing tube 120, must be composed of a very flexible material with sufficient tensile strength to undergo the stress encountered when the source wire 10 is maneuvered to a treatment site. Therefore, backbone wire 130 should be constructed of a material with properties similar to that of housing tube 120. In fact, if the backbone wire 130 is welded to the distal end of tube 120 then the backbone wire 130 and tube 120 should be made of the same material, for example a titanium/nickel alloy as described above. For ease of initially inserting the backbone wire 130 into the tube 120 and to allow greater pivoting of the assembly while reducing stress to the housing material, the proximal end 170 of the backbone wire 130 is rounded. Other configurations of backbone wire 130 will be discussed in the description of other embodiments of the invention.
A third component of source wire 10 is a radioactive core 160. Radioactive core 160 may be composed of a variety of different radioisotopes such as Ir-192, Cs-137, Co-57, Co-60, Sr-89, Sr-90, P-32, Y-90, Au-198, 1-125, Pd-103, Se-75, Ru-106, Yb-169, or Am-241. However, the preferred embodiment of core 160 will consist of a substantially pure iridium, which has been irradiated in a nuclear reactor to produce Ir-192 of a predetermined strength appropriate to its weight. Core 160 has a diameter that is smaller than the inner diameter of housing tube 120. Core 160 is inserted in the proximal end of the lumen of tube 120 and is pushed inward until core 160 abuts the rounded end 170 of backbone wire 130. A plurality of radioactive cores 160 may also be employed in the present invention.
A preferred embodiment of the invention has a radioactive core 160 of at least 20 mm in length that emits about 380 keV of energy. By spreading out the 380 keV emitted over at least a 20 mm distance, the core 160 is directly visible with a fluoroscope. Although the energy emitted by the radioactive core 160 and the length of the source of radioactivity will vary with different embodiments of the invention, the preferred embodiment will have a radioactive core that can be seen with a fluoroscope. This feature provides a distinct advantage over the currently available sources which have a radioactive core of 10 mm or less in length. These point sources emit the equivalent 380 keV of energy in a less diffused manner. Thus the emitted energy hits the fluoroscope directly and overrides its ability to visualize the radioactive source. Therefore, the radioactive cores of currently available source wires are not directly visible with a fluoroscope and must be positioned inside the body without the visual confirmation allowed with the present invention.
A preferred embodiment of the invention has a core 160 that is about 0.005" in diameter. Thus, in this embodiment the core 160 is smaller in diameter than the backbone wire 130 thereby providing increased flexibility to the proximal end of the source wire 10. In fact, when core 160 has a smaller diameter than backbone wire 130, the end of the source wire housing core 160 will have more flexibility than the portion of the source wire containing the backbone wire 130. This increased flexibility at the front end of the source wire will allow the source wire to maneuver easier through tight bends and curves.
Once the core 160 has been inserted into source wire 10 the proximal end 140 of tube 120 is rounded using an arc welder, such as a tungsten inert gas (or ΗG) welder. The purpose of the rounded end of source wire 10 is to seal radioactive core 160 within the interior of tube 120 and to facilitate the advancement of the source wire 10 through an implanted catheter to the treatment site. FIGURE 2 illustrates a second embodiment 20 of the present invention. This embodiment is similar in many respects to the embodiment shown in FIGURE 1 and will have the same reference numerals as the respective elements pictured in FIGURE 1. This embodiment also has an elongated cylindrical metal housing tube 120, similar in dimensions and characteristics to the tube described with respect to FIGURE 1. A backbone wire 130, preferably constructed from the same material as the housing tube 120, is introduced to the interior of the housing tube 120 and extends from the distal end 150 thereof to an area positioned several millimeters (preferably about 32 mm) from the proximal end 140 of the tube 120. The backbone wire 130 is provided with rounded end 170 to aid its movement within the tube 120 and to allow greater pivoting of the assembly while reducing stress to the housing material.
A radioactive core 160 is enclosed within a thin- walled capsule 220. This capsule 220 is inserted into tube 120 so that the distal end 230 of capsule 220 abuts the rounded end 170 of the backbone wire 130. The capsule 220 should be flexible and the wall of capsule 220 should be manufactured to a thickness of between 0.001" and 0.0005". This thin capsule 220 should be made of a material that allows the passage of neutrons without obtaining significant radioactivity itself. Thus, should the capsule material become radioactive by neutron flux, the material and any contaminants of that material should have a shoπ half-life as compared to the radioactive core 160. It is important that the capsule 220 should emit less than 10% of the radiation emitted by core 160. The capsule 220 may be made in a variety of ways. For example, it may be made from a carbon filament sealed with epoxy on both ends, or it may be made of a very thin metallic substance (e.g., titanium, a high purity aluminum such as aluminum 1100, platinum, or the titanium/nickel alloy described previously) with both ends welded, soldered, or glued closed. In a preferred embodiment the iridium will be encapsulated before it is irradiated to form Ir-192 and the capsule 220 will allow the passage of neutrons to irradiate the core 160. Once the capsule 220 has been positioned within housing tube 120 adjacent to backbone wire 130 an optional plug 250 may be inseπed next to the proximal end 225 of capsule 220. When the desired components have been appropriately positioned, the proximal end 140 of source wire 20 is sealed and rounded as described above. A preferred embodiment of the invention will seal proximal end 140 by fusing the proximal end of tube 120 with an arc welder (when plug 250 is not incorporated into the source wire). Alternatively, the proximal end of source wire 20 can be sealed and rounded by welding, gluing, or soldering the plug 250 to the proximal end of tube 120 and rounding the proximal end with a router, grinder, sander, etc. to achieve a rounded end 140.
The preferred embodiment of capsule 220 will be rounded on both ends. The purpose of having a rounded distal end 230 of capsule 220 is to allow greater pivoting of the source wire
20 while reducing stress to the housing material at the juncture of backbone wire 130 and capsule 220. Although the preferred embodiment has a single capsule 220, a plurality of capsules could be employed in the present invention, or a plurality of cores 160 could be incorporated within a single capsule 220. FIGURE 3 illustrates an additional embodiment of a flexible source wire 30, this source wire is similar in most respects to the embodiments shown in FIGURES 1 and 2. In this embodiment, similar elements in FIGURE 1 will have the same reference numerals as their respective elements in FIGURE 3. FIGURE 3 shows a source wire in which radioactive core 160 is located within an open-ended capsule 330. This capsule 330 is like capsule 220, except that it is open on the end proximate to the proximal end of the source wire 30. When open-ended capsule 330 is used, an optional plug 350 may be placed over the open end of capsule 330 before it is sealed. Open ended capsule 330 may be sealed by welding the proximal end of the capsule 330 to the proximal end of the tube 120, if the capsule 330 and the tube 120 are made of the same material. Alternatively, if plug 350 is used then plug 350 may be composed of the same material as tube 120 and may thus be welded to the proximal end 140 of tube 120. However, alternative means of sealing the proximal end of capsule 330 and tube 120 may also be employed.
Open-ended capsule 330, like capsule 220 shown in FIGURE 2, is positioned adjacent to rounded end 170 of backbone wire 130. The distal end 340 of open-ended capsule 330 is rounded to facilitate bending of source wire 30 at the juncture of backbone wire 130 and open-ended capsule 330.
FIGURE 7 illustrates an alternative embodiment of the source wire where the backbone wire consists of a series of ball-like structures 705 interconnected with short lengths of a thin wire 708. This configuration provides increased flexibility throughout the length of the source wire with each ball acting as a pivoting agent and relieving stress to the wall of housing tube 120. FIGURE 7 also shows radioactive source 160 having a thin coating 712 of a neutron permeable material. The coating 712 may be an electroplated coating of a material such as gold, titantium, platinum, ec Coating 712 may also be made of non-metallic materials such as a hardening agent (e.g., glue or acrylic). Coating 712 may be applied to core 160 by brushing, dipping, painting or molecularly bonding the coating material to the outer surface of core 160.
Coating 712 will completely cover the outside surface of core 160 and will function to prevent the flaking of the radioactive core 160.
FIGURE 4A shows a preferred embodiment of the present invention. This embodiment of a flexible source wire 40 is similar in many respects to the embodiments shown in FIGURES
1 and 3. Therefore the elements in FIGURE 4 corresponding to similar elements in FIGURES
1 and 3 are given the same reference numerals as their respective elements in FIGURES 1 and 3. The embodiment illustrated in FIGURE 4A has a different configuration of its backbone wire to that shown in any of the other embodiments and includes an untapered portion 430, a tapered portion 440, and a rounded area 450. The backbone wire of source wire 40 is tapered at its proximal end. Backbone wire 420 is tapered over approximately the last 0.5" to 2.0" of its proximal end. The taper 440 goes from a 100% width of the untapered backbone wire 430 to about 30% to 60% of the width of the untapered backbone wire 430 as the taper extends toward the proximal end of source wire 40. Taper 440 of backbone wire 420 terminates in a rounded area 450, where rounded area 450 approximates the shape of a ball. This configuration allows the source wire 40 to release some of the stress on the outer wall of housing tube 120 when the source wire bends to transverse a tight comer. In fact the stress placed on rounded area 450 and translated to backbone wire 420 will cause the backbone wire to crumple along the tapered area as illustrated in FIGURE 4B. However, since the backbone wire 420 is made from a flexible material that exhibits little or no memory retention when it is bent, or more specifically a material that can accept up to a 1% strain with less than a 1% alteration in its original shape, the backbone wire 420 will resume its original shape when the stress is removed and the source wire traverses a straight passage. The novel design of backbone wire 420 increases the flexibility and maneuverability of the source wire 40, as well as decreasing the stress on the wall of housing tube 120. By decreasing the stress on housing tube 120, this backbone design allows the use of a smaller diameter source wire than is currently available.
An optional feature of each of the source wire embodiments is to attach the backbone wire 130 or 420 to the inner surface of the housing tube 120 by welding, fusing, soldering, gluing, etc. Sites of attachment 168 are shown in FIGURES 1-4. These sites of attachment 168 provide an internal safety device that insures that if the housing tube 120 were to break that the radioactive core 160 would not separate from the backbone wire 130 and could be retracted from the patient. FIGURES 5 A through C illustrate what happens if the housing tube 120 breaks and the backbone wire 130 is not attached to the inner surface of tube 120. FIGURE 5B shows where tube 120 has broken and FIGURE 5C shows how the radioactive core 160 would be left in the patient when the backbone wire 130 was retracted. In contrast, when backbone wire 130 is attached to the inner surface of tube 120 at attachment sites 168, as seen in FIGURE 5D, if the metal housing tube 120 breaks at any point distal to attachment sites 168 then the radioactive core- 160 will still be attached to the backbone wire 130 and will be retracted from the patient when the backbone wire 130 is withdrawn, as seen in FIGURE 5E. Another optional feature of the source wires described herein is to provide a seal 178 between the inner surface of housing tube 120 and backbone wire 130 by welding, fusing, soldering, gluing, etc. the backbone wire to the interior surface of housing tube 120. This seal 178 could also serve as an attachment site 168. Seal 178 may be made by a number of methods. One such method would be to thread the backbone wire 130 through the length of the housing tube. The distal end of the wire would be marked at the point where the proximal end of the wire is flush with the proximal end of the housing tube 120. The backbone wire would then be pushed forward and a small amount of slow drying epoxy placed around the circumference of the backbone wire 130 about two centimeters from the proximal end of the wire. Once the epoxy is added to the wire, the wire would be pulled back into the housing tube until the mark on the distal end extended from the distal end of the housing tube the appropriate distance, preferably about 32 mm. The backbone wire would then be cut flush with the distal end of the wire and welded to the housing tube to seal the distal end of the backbone wire 130. Any glue adhering to the internal surface of the proximal portion of the housing tube, where the epoxied backbone wire was drawn through the housing tube, would be reemed out before the radioactive core 160 was inserted into the backbone wire.
An alternative method of producing a seal 178 would be to follow the procedure described above, except to allow the epoxy to dry before drawing the proximal end of the backbone wire back into the housing tube. The epoxy ring would then be ground or sanded to fit snugly within the housing tube 120. Seal 178 would encircle backbone wire 130 closing off gap 175 and thereby preventing any "flakes" from the radioactive core 160 from migrating through gap 175 between the backbone wire 130 and the inner surface of housing tube 120. Seal 178 is typically incorporated into embodiments of the invention where radioactive core 160 is not enclosed in a capsule or encapsulated as seen in FIGURE 1 and FIGURE 4C.
Seal 178 and attachment site 168 are produced in a similar manner. The major difference between seal 178 and attachment site 168 is that attachment site 168 may only attach a small segment of the diameter of backbone wire 130 to the inner surface of the housing tube 120. Thus, gap 175 may not be totally closed all around the backbone wire 130 when the backbone wire 130 is only attached to the inner surface of tube 120 at a small portion of its circumference as may happen in forming an attachment site.
Yet another optional feature of the source wires described herein (but not shown) would be to coat the exterior surface of the source wire with a non-oxidizing agent, such as gold In one embodiment of the present invention, a thin gold layer (from approximately 1 to 10 microns thick) would be electroplated over the outer surface of metal tube 120, or at least that portion of the surface overlying the radioactive core 160 and preferably extending over the proximal end 140 of the source wire. Furthermore, the gold coating of the source wire would preferably be done prior to loading the radioactive core 160 into housing tube 120.
The fabrication of the source wires shown in FIGURES 1-4 is described below. The first step in the manufacture of the described source wires is to obtain the metal tubing that will be used to make the housing tube 120. Once the tubing is acquired, a calibrated micrometer for measuring the outside diameter and calibrated rods for measuring the inside diameter are used to validate that the tubing meets the manufacturer's specifications. The preferred embodiment of the present invention uses Tinel Alloy BB tubing of an external diameter of 0.014 from Raychem Corporation. The backbone wire is also commercially obtained. For the backbone wire 130, a solid wire of Tinel Alloy BB is ordered that has a diameter of 0.0085". Rounded end 170 of backbone wire 130 is produced using the heat from a TIG welder.
Backbone wire 420 is made by taking the Tinel Alloy BB wire ordered and grinding it down with an electric sander. The wire is held in a pin vise and rotated while grinding to taper the wire. The tapering can be done automatically or manually. The tapered end is examined under a microscope and with a micrometer to ensure that it is tapered sufficiently (i.e., with the right degree of reduction in the diameter of the wire and that it is evenly tapered). Once the appropriate taper of backbone wire 420 is achieved then the rounded area 450 is formed on the tapered end of backbone wire 420. The rounded area 450 is formed by heating the tapered end of backbone wire 420 with an arc welder after placing the tapered end of backbone wire 420 into a heat sink (preferably made of aluminum, copper, brass, or any other material that will absorb heat away from the protected object) at a predetermined distance above the heat sink. The dimensions of the rounded area 450, or ball, will be determined by the gap between the top of the wire and the bottom of the tungsten welding rod and by the length of the wire above the heat sink 650 that is exposed to the heat of the ΗG welder. Typically the wire is placed 0.025" (or about 0.1 mm) above the heat sink 650 using a feeler gauge. A feeler gauge is also used to set a gap of about 0.030" between the top of the wire and the bottom of the welding rod. Once the tapered end of backbone wire 420 is placed the proper distance from the heat sink 650 and welding rod, the tapered end of the wire 420 is exposed to a TIG welder. The metal above the heat sink 650 will melt and form a rounded area 450. Typically, the rounded area will be a ball of about 0.0085" in diameter, or of a similar diameter as the untapered backbone wire.
Next a wire of about 32 mm in length is threaded into the lumen of the housing tube at what will become the proximal end 140 of the tube 120. The backbone wire 130 or 420 is then threaded through the distal end of the lumen of the housing tube 120 until it reaches the 32 mm wire placed at the proximal end of the tube 120. The backbone wire is marked where it exits the distal end of the tube 120. The backbone wire is then cut at the mark and is rethreaded into the lumen of the housing tube 120 so that the cut end of backbone wire 130 or 420 is flush with the distal end of housing tube 120. The distal end of the wire is then welded to the distal end of tube 120 with a ΗG welder. This provides a rounded end 150 of the source wire that has a slightly larger diameter than tube 120 and provides an end that can be inserted into an afterloader, where the source wire can be held in place by the rounded end 150 and a set screw that is tightened into the wire just below the rounded end 150.
Next the 32 mm wire that was placed in the proximal end of housing tube 120 is removed. The proximal end of the housing tube 120 is then set about 0.025" above a heat sink
650. The heat sink 650 is also used as a clamping device to hold the wire in place. A gap of about 0.035" is set between the top of the housing tube 120 and the bottom of the welding rod.
Then an iridium fiber, which has been irradiated in a nuclear reactor to the desired radioactivity and held for 11 to 14 days to purge the iridium fiber of any short lived radioactive contaminants, is removed from its container. The iridium fiber may or may not be encapsulated as described above. The iridium fiber is preferably 30 mm in length and about 0.005" in outside diameter.
The radioactive iridium fiber is loaded into the housing tube 120 using a funnel. The iridium fiber is made flush with the bottom of the funnel. A small rod, having a proper length and outside diameter, is used to countersink the Ir-192 about 2 mm from the top of the housing mbe 120. The funnel is then removed. The assembly of the radioactive core 160 into the housing mbe 120 is done using hand manipulators behind a leaded glass with lead shields so that the human assembler is not exposed to radiation. The forceps, funnel and heat sink used during the process that may have touched the radioactive core 160 must be decontaminated or disposed of properly.
Once the iridium fiber, or encapsulated fiber, is set in the proximal end of the housing mbe 120, as illustrated in FIGURE 6, the exposed proximal end of mbe 120 is subjected to the heat of a ΗG welder. This fuses the exposed end of the housing mbe or welds it to plug 350, if 350 plug is present Without the heat sink the heat would go directly to the iridium fiber and would oxidize, vaporize or fracture the iridium core 160 causing contamination of the outside surface of the source wire rendering it unusable. However, if the housing mbe is placed a distance Y above the heat sink 650 and the radioactive core 160 is placed a distance X below the top of the heat sink 650 then the ΗG welder will cause the mbe 120 to seal the proximal end 140 of the source wire without affecting the radioactive core 160. As long as the distances between the top of the housing mbe and the heatsink, as well as the top of the housing tube and the bottom of the welding rod are correct, a rounded surface ranging from about 0.016" to about
0.018" in diameter results. The size of the rounded area is verified with gauges so that the resulting source wire will fit into the internal diameter of the positioning catheter that is used to properly place the radioactive source wire at the treatment site. Once the source wire has been fabricated, it is wiped clean with swabs and loaded into a lead container to await use in a patient
Having described several embodiments of the new and improved flexible source wire for radiation treatment in accordance with the present invention, it is believed that other modifications, variations and changes will be suggested to those skilled in the an in view of the description set forth above. It is therefor to be understood that all such variations, modifications and changes are believed to fall within the scope of the invention as defined in the appended claims.

Claims (36)

WHAT IS CLAIMED IS:
1. A source wire for radiation treatment of disease within a body comprising: a generally cylindrical elongated housing tube having an outer surface, an interior surface, a distal end and a rounded proximal end, said tube constructed of a material that can accept up to a 1% strain with less than a 1% permanent alteration in its original configuration; a flexible backbone wire having a first end and a second end, said wire encased and secured within said housing mbe wherein said first end is adjacent to said distal end of said tube and said second end is rounded; and means for emitting radioactivity, said radioactive means localized within said housing mbe adjacent to said rounded second end of said wire and proximate to said proximal end of said housing tube, wherein said proximal end is sealed to prevent the release of said radioactive core.
2. The source wire of claim 1, wherein said radioactive means has a smaller outer diameter than said flexible backbone.
3. The source wire of claim 1 , wherein said housing tube is made of a titanium/nickel alloy.
4. The source wire of claim 3, wherein said titanium/nickel alloy is composed of about 55% nickel and about 45% titantium.
5. The source wire of claim 1, wherein an outer diameter of said housing tube is from about 0.012 in. to about 0.018 in.
6. The source wire of claim 1, wherein said backbone wire is made of the same material as said housing mbe.
7. The source wire of claim 1 , wherein the first end of said backbone wire is attached to the distal end of said housing tube.
8. The source wire of claim 1, wherein said backbone wire is affixed to said interior surface of said housing tube at more than one site.
9. The source wire of claim 1, wherein said outer surface of said housing tube is coated with a non-oxidizing agent
10. The source wire of claim 9, wherein said non-oxidizing agent is gold.
11. The source wire of claim 1 , wherein said radioactive means can be visualized with a flurorscope.
12. The source wire of claim 1, wherein said radioactive means comprises Ir-192.
13. The source wire of claim 1, wherein said radioactive means is at least 20 mm in length.
14. The source wire of claim 1, wherein said radioactive means is encapsulated within a thin- walled neutron permeable material prior to being localized within said housing mbe.
15. The source wire of claim 14, wherein said encapsulating material is gold, epoxy, carbon, titanium, platium, nickel, high purity aluminum, or mixtures thereof.
16. The source wire of claim 1, further comprising a sealing device located between said backbone wire and said inner surface of said housing tube; said sealing device encircles said backbone wire to prevent radioactive material from migrating along said housing tube distal to said sealing device.
17. The source wire of claim 1, wherein said backbone wire includes an untapered portion, a tepered region, and a rounded area, said rounded area adjacent to said radioactive means.
18. The source wire of claim 17, wherein said tapered region of said backbone wire extends from about 0.5 inches to about 2.0 inches proximate to said rounded area.
19. T e source wire of claim 1, wherein said backbone wire comprises a series of rounded ball-like sections interconnected by a wire having a smaller diameter than said ball-like sections.
20. The source wire of claim 1 further comprising means for reducing stress at said proximal end of said backbone wire.
21. The source wire of claim 20 wherein said stress reducing means includes a rounded area on said second end of said backbone wire, said rounded area being adjacent to said radioactive core and attached to a tapered region of said backbone wire.
22. The source wire of claim 1, wherein said radioactive means is a single radioactive source.
23. The source wire of claim 1, wherein said radioactive means comprises a plurality of radioactive sources.
24. A source wire for radiation treatment of disease within a body comprising: a generally cylindrical elongated housing mbe having an outer surface, an interior surface, a distal end and a rounded proximal end, said mbe constructed of a material that can accept up to a 1% strain with less than a 1% permanent alteration in its original configuration; a flexible backbone wire having a first end and a second end, said wire encased and secured within said housing mbe wherein said first end is adjacent to said distal end of said tube and said second end is rounded and a capsule localized within said housing tube adjacent to said rounded second end of said wire and proximate to said proximal end of said housing tube; means for emitting radioactivity, said radioactive means situated within said capsule; and wherein said proximal end of said housing tube is sealed to prevent the release of said radioactive core.
25. A source wire for radiation treatment of disease within a body comprising: a generally cylindrical elongated housing mbe having an outer surface, an interior surface, a distal end and a rounded proximal end, said mbe constructed of a material that can accept up to a 1% strain with less than a 1% permanent alteration in its original configuration; a flexible backbone wire having a first end and a second end, said wire encased and secured within said housing mbe wherein said first end is adjacent to said distal end of said mbe and said second end is rounded; and an encapsulated radioactive core localized within said housing mbe adjacent to said rounded second end of said wire and proximate to said proximal end of said housing mbe, wherein said proximal end of said housing mbe is sealed to prevent the release of said radioactive core.
26. A source wire for radiation treatment of disease within a body comprising: a generally cylindrical elongated housing tube having an outer surface, an interior surface, a distal end, and a rounded proximal end, said tube constructed of a nickel/titanium alloy; a flexible backbone wire having a first end and a second end, said wire encased within said housing tube wherein said first end is attached to said distal end of said tube and said second end is rounded and adjoins a tapered area of said backbone wire, said backbone wire being affixed to said interior surface of said housing tube at one or more points; and a radioactive core localized within said housing tube adjacent to said rounded second end of said wire and proximate to said proximal end of said housing tube, wherein said radioactive core has a smaller diameter than said backbone wire; and wherein said proximal end of said housing tube is sealed to prevent the release of said radioactive core.
27. A process for manυfacπiring a radioactive source wire for irradiating diseased tissue, said process comprising the steps of: providing a thin, flexible tube, said tube having an outer surface, an interior surface, a distal end, a proximal end, and a lumen of a predetermined diameter, inserting a flexible backbone wire into the lumen of said distal end of said tube for a predetermined distance; inserting a radioactive core into the lumen of said proximal end of said tube until it abuts said flexible wire; and sealing said distal end and said proximal end of said tube.
28. The process of claim 27 further comprising the step of attaching said backbone wire to said interior surface of said tube at one or more points.
29. The process of claim 27 wherein said radioactive core has a smaller outer diameter than said flexible backbone.
30. The process of claim 27, wherein said tube is made of a nickel/titanium alloy.
31. The process of claim 27, wherein said tube and said backbone wire are composed of the same material.
32. The process of claim 27, further comprising the step of coating said outer surface of said source wire with a non-oxidizing agent
33. The process of claim 27, further comprising the step of providing a seal between said backbone wire and said housing tube along a portion of said housing tube.
34. The process of claim 27, wherein said radioactive core is encapsulated in a neutron permeable material prior to being inserted into said mbe.
35. A process for manufacturing a radioactive source wire for irradiating diseased tissue, said process comprising the steps of: providing a thin, flexible tube, said mbe having an outer surface, an interior surface, a distal end, a proximal end, and a lumen of a predetermined diameter, inserting a flexible backbone wire into the lumen of said distal end of said tube for a predetermined distance; inserting a capsule into the lumen of said proximal end of said tube until it abuts said flexible wire; inserting a radioactive core into said capsule; and sealing said distal end and said proximal end of said tube.
36. A process for manufacturing a radioactive source wire for irradiating diseased tissue, said process comprising the steps of: providing a thin, flexible tube, said mbe having an outer surface, an interior surface, a distal end, a proximal end and a lumen of a predetermined diameter, said mbe being made of a nickel/titanium alloy; providing a flexible backbone wire made of a nickel/titanium alloy, said backbone wire having a first end and a second end; tapering said first end of said backbone wire, said tapered area having a smaller end and a larger end wherein said larger end of said tapered portion adjoins an untapered portion of said backbone wire; rounding said smaller end of said tapered area of said backbone wire; inserting said smaller end of said tapered portion into the lumen of said distal end of said mbe for a predetermined distance; welding said second end of said backbone wire to said distal end of said tube; attaching said backbone wire to said interior surface of said housing tube at one or more sites; inserting a radioactive core into the lumen of said proximal end of said tube until said radioactive core abuts said flexible wire; and fusing said proximal end of said tube to prevent the release of said radioactive core.
AU61498/96A 1995-06-07 1996-06-07 Flexible source wire for localized internal irradiation of tissue Ceased AU696822B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/480,307 US5857956A (en) 1994-06-08 1995-06-07 Flexible source wire for localized internal irradiation of tissue
US480307 1995-06-07
PCT/US1996/008688 WO1996040352A1 (en) 1995-06-07 1996-06-07 Flexible source wire for localized internal irradiation of tissue

Publications (2)

Publication Number Publication Date
AU6149896A true AU6149896A (en) 1996-12-30
AU696822B2 AU696822B2 (en) 1998-09-17

Family

ID=23907457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61498/96A Ceased AU696822B2 (en) 1995-06-07 1996-06-07 Flexible source wire for localized internal irradiation of tissue

Country Status (6)

Country Link
US (3) US5857956A (en)
EP (1) EP0954351A4 (en)
JP (1) JP2001517096A (en)
AU (1) AU696822B2 (en)
CA (1) CA2222149A1 (en)
WO (1) WO1996040352A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184496T1 (en) 1993-07-01 1999-10-15 Schneider Europ Gmbh MEDICAL DEVICES FOR THE TREATMENT OF BLOOD VESSELS USING IONIZATION RADIATION
US5857956A (en) 1994-06-08 1999-01-12 United States Surgical Corporation Flexible source wire for localized internal irradiation of tissue
DE69413209T2 (en) 1994-06-10 1999-03-04 Schneider Europ Gmbh Medicinal device for the treatment of a part of body vessels by means of ionizing radiation
DE69426071T2 (en) 1994-06-24 2001-05-10 Schneider (Europe) Gmbh, Buelach Medicinal device for the treatment of a part of a body vessel by means of ionizing radiation
US5683345A (en) 1994-10-27 1997-11-04 Novoste Corporation Method and apparatus for treating a desired area in the vascular system of a patient
US5833593A (en) * 1995-11-09 1998-11-10 United States Surgical Corporation Flexible source wire for localized internal irradiation of tissue
US5855546A (en) 1996-02-29 1999-01-05 Sci-Med Life Systems Perfusion balloon and radioactive wire delivery system
US6099454A (en) 1996-02-29 2000-08-08 Scimed Life Systems, Inc. Perfusion balloon and radioactive wire delivery system
US6234951B1 (en) 1996-02-29 2001-05-22 Scimed Life Systems, Inc. Intravascular radiation delivery system
NL1003528C2 (en) 1996-07-05 1998-01-07 Optische Ind Oede Oude Delftoe Assembly of a capsule for brachytherapy and a guide.
US6676590B1 (en) 1997-03-06 2004-01-13 Scimed Life Systems, Inc. Catheter system having tubular radiation source
US6110097A (en) 1997-03-06 2000-08-29 Scimed Life Systems, Inc. Perfusion balloon catheter with radioactive source
US6312374B1 (en) 1997-03-06 2001-11-06 Progenix, Llc Radioactive wire placement catheter
US6059713A (en) 1997-03-06 2000-05-09 Scimed Life Systems, Inc. Catheter system having tubular radiation source with movable guide wire
US6059812A (en) 1997-03-21 2000-05-09 Schneider (Usa) Inc. Self-expanding medical device for centering radioactive treatment sources in body vessels
US6019718A (en) 1997-05-30 2000-02-01 Scimed Life Systems, Inc. Apparatus for intravascular radioactive treatment
EP1019145A1 (en) 1997-09-23 2000-07-19 United States Surgical Corporation Source wire for radiation treatment
ATE227145T1 (en) 1997-09-26 2002-11-15 Schneider Europ Gmbh BALLOON CATHETER INFLATED WITH CARBON DIOXIDE FOR RADIOTHERAPY
US6254552B1 (en) * 1997-10-03 2001-07-03 E.I. Du Pont De Nemours And Company Intra-coronary radiation devices containing Ce-144 or Ru-106
US6264596B1 (en) 1997-11-03 2001-07-24 Meadox Medicals, Inc. In-situ radioactive medical device
US6120540A (en) * 1998-01-21 2000-09-19 Apple; Marc G. Radio prosthesis
US6413203B1 (en) 1998-09-16 2002-07-02 Scimed Life Systems, Inc. Method and apparatus for positioning radioactive fluids within a body lumen
ATE293472T1 (en) 1999-02-16 2005-05-15 Cordis Corp MANUAL SYSTEM FOR DELIVERY OF A TAPE DURING INTRAVASCULAR RADIATION THERAPY
US6132677A (en) * 1999-04-26 2000-10-17 Lockheed Martin Energy Research Corporation Method for making radioactive metal articles having small dimensions
EP1060765B1 (en) * 1999-06-18 2004-12-29 AEA Technology QSA GmbH Radiation source for endovascular radiation treatment
MXPA02000375A (en) 1999-07-14 2002-07-30 Novoste Corp Radioactive source train.
US6352500B1 (en) 1999-09-13 2002-03-05 Isotron, Inc. Neutron brachytherapy device and method
US6319189B1 (en) 1999-09-13 2001-11-20 Isotron, Inc. Methods for treating solid tumors using neutron therapy
US6352501B1 (en) 1999-09-23 2002-03-05 Scimed Life Systems, Inc. Adjustable radiation source
US6203485B1 (en) 1999-10-07 2001-03-20 Scimed Life Systems, Inc. Low attenuation guide wire for intravascular radiation delivery
US6398709B1 (en) 1999-10-19 2002-06-04 Scimed Life Systems, Inc. Elongated member for intravascular delivery of radiation
US6436026B1 (en) * 1999-10-22 2002-08-20 Radiomed Corporation Flexible, continuous, axially elastic interstitial brachytherapy source
US6629920B2 (en) 2000-01-07 2003-10-07 Interventional Therapies Energy filtering system
US6416457B1 (en) 2000-03-09 2002-07-09 Scimed Life Systems, Inc. System and method for intravascular ionizing tandem radiation therapy
US6302865B1 (en) 2000-03-13 2001-10-16 Scimed Life Systems, Inc. Intravascular guidewire with perfusion lumen
US6817995B1 (en) 2000-04-20 2004-11-16 Isotron ,Inc. Reinforced catheter connector and system
US6497645B1 (en) 2000-08-28 2002-12-24 Isotron, Inc. Remote afterloader
IL155740A0 (en) * 2000-11-08 2003-12-23 Theragenics Corp Radioactive source wire and dual lumen catheter system for brachytherapy
WO2002040092A2 (en) * 2000-11-14 2002-05-23 Apple Marc G Directional energy emitting implant
US6875165B2 (en) * 2001-02-22 2005-04-05 Retinalabs, Inc. Method of radiation delivery to the eye
US6669621B2 (en) * 2001-03-14 2003-12-30 Cordis Corporation Method and assembly for containing radioactive materials
US6723052B2 (en) * 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
CA2453822C (en) * 2001-08-03 2011-02-22 Tyco Healthcare Group Lp Tissue marking apparatus and method
US6773390B2 (en) * 2002-03-20 2004-08-10 Cordis Corporation Radioactive source ribbon assembly
US8521284B2 (en) 2003-12-12 2013-08-27 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
US7563222B2 (en) * 2004-02-12 2009-07-21 Neovista, Inc. Methods and apparatus for intraocular brachytherapy
ATE488269T1 (en) * 2004-02-12 2010-12-15 Neovista Inc DEVICE FOR INTRAOCULAR BRACHYTHERAPY
NL1026323C2 (en) * 2004-06-03 2005-12-06 Isodose Control B V HDR device.
CN102512281A (en) 2005-11-15 2012-06-27 内奥维斯塔公司 Methods and apparatus for intraocular brachytherapy
JP2010504174A (en) * 2006-09-21 2010-02-12 クレベニー テクノロジーズ Specially constructed and surface-modified medical devices with certain design features that take advantage of the unique properties of tungsten, zirconium, tantalum, and / or niobium
US20090054874A1 (en) * 2007-08-23 2009-02-26 C. R. Bard, Inc. Multi-lumen catheter including a lumen having a variable cross sectional area
CA2724327A1 (en) 2008-06-04 2009-12-10 Neovista, Inc. Handheld radiation delivery system for advancing a radiation source wire
US9233259B2 (en) * 2013-03-12 2016-01-12 Hesham E. Gayar Skin HDR brachytherapy multichannel applicators and methods of brachytherapy treatment
WO2017184820A1 (en) * 2016-04-20 2017-10-26 The Cleveland Clinic Foundation Catheter assembly
US11541251B2 (en) 2018-09-26 2023-01-03 University Of Iowa Research Foundation Apparatus and method for rotating shield brachytherapy
US20220105362A1 (en) * 2019-02-11 2022-04-07 University Of Iowa Research Foundation Re-activatable radiation source for brachytherapy
US11504546B2 (en) 2019-02-28 2022-11-22 Cowles Ventures, Llc Needle guidance device for brachytherapy and method of use
US11524176B2 (en) 2019-03-14 2022-12-13 Cowles Ventures, Llc Locator for placement of fiducial support device method

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US857992A (en) 1901-10-16 1907-06-25 Raymond B Gilchrist Cork-extractor.
US1494826A (en) * 1920-09-29 1924-05-20 Standard Chemical Company Radium applicator
US1543859A (en) * 1922-10-27 1925-06-30 United States Radium Corp Radium therapeutic device
US1753287A (en) 1925-05-15 1930-04-08 Failla Gioacchino Method and means for applying radium emanation
US1954868A (en) 1929-12-18 1934-04-17 Failla Gioacchino Method and means for treatment by radiations
US2476644A (en) 1947-09-27 1949-07-19 United States Radium Corp Radioactive metallic foil products
US2546761A (en) 1950-01-13 1951-03-27 Radium Chemical Company Inc Radium nasopharyngeal applicator
US3351049A (en) * 1965-04-12 1967-11-07 Hazleton Nuclear Science Corp Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture
US3567943A (en) 1967-07-19 1971-03-02 Nuclear Radiation Developments Radioactive plating for radioactive foils
SE318971B (en) * 1968-05-02 1969-12-22 Atomenergi Ab
DE2308443A1 (en) * 1972-02-22 1973-08-30 Univ Erasmus EXAMINATION DEVICE WITH CATHETER FOR EXAMINING A HOLLOW ORGAN WITH THE AID OF ULTRASOUND WAVES AND METHOD OF MAKING THE CATHETER
US4003369A (en) * 1975-04-22 1977-01-18 Medrad, Inc. Angiographic guidewire with safety core wire
US4323055A (en) * 1980-04-08 1982-04-06 Minnesota Mining And Manufacturing Company Radioactive iodine seed
US4385635A (en) 1980-04-25 1983-05-31 Ruiz Oscar F Angiographic catheter with soft tip end
US4359812A (en) * 1981-01-14 1982-11-23 General Electric Company Method of making a joint
US4697575A (en) * 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4702228A (en) * 1985-01-24 1987-10-27 Theragenics Corporation X-ray-emitting interstitial implants
US4922923A (en) * 1985-09-18 1990-05-08 C. R. Bard, Inc. Method for effecting a catheter exchange
US5141487A (en) * 1985-09-20 1992-08-25 Liprie Sam F Attachment of radioactive source and guidewire in a branchy therapy source wire
US5322499A (en) 1985-09-20 1994-06-21 Liprie Sam F Continuous sheated low dose radioactive core adapted for cutting into short sealed segments
US4763642A (en) * 1986-04-07 1988-08-16 Horowitz Bruce S Intracavitational brachytherapy
US4819618A (en) * 1986-08-18 1989-04-11 Liprie Sam F Iridium/platinum implant, method of encapsulation, and method of implantation
US4841976A (en) * 1987-12-17 1989-06-27 Schneider-Shiley (Usa) Inc. Steerable catheter guide
USRE34466E (en) * 1987-12-23 1993-12-07 Advanced Cardiovascular Systems, Inc. Extendable guidewire for cardiovascular procedures
US4994013A (en) * 1988-07-28 1991-02-19 Best Industries, Inc. Pellet for a radioactive seed
US4891165A (en) * 1988-07-28 1990-01-02 Best Industries, Inc. Device and method for encapsulating radioactive materials
US5084002A (en) * 1988-08-04 1992-01-28 Omnitron International, Inc. Ultra-thin high dose iridium source for remote afterloader
US5067489A (en) * 1988-08-16 1991-11-26 Flexmedics Corporation Flexible guide with safety tip
US5183455A (en) * 1988-10-07 1993-02-02 Omnitron International, Inc. Apparatus for in situ radiotherapy
US4976680A (en) * 1988-10-07 1990-12-11 Hayman Michael H Apparatus for in situ radiotherapy
US4861520A (en) * 1988-10-28 1989-08-29 Eric van't Hooft Capsule for radioactive source
KR940005307B1 (en) * 1989-04-28 1994-06-16 또낀 코포레이션 Readily operable catheter guide wire using shape memory alloy with pseudo elasticity
US5147282A (en) 1989-05-04 1992-09-15 William Kan Irradiation loading apparatus
US5059166A (en) 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia
US5199939B1 (en) * 1990-02-23 1998-08-18 Michael D Dake Radioactive catheter
US5095911A (en) * 1990-05-18 1992-03-17 Cardiovascular Imaging Systems, Inc. Guidewire with imaging capability
US5342283A (en) * 1990-08-13 1994-08-30 Good Roger R Endocurietherapy
JPH0683726B2 (en) * 1990-10-12 1994-10-26 日本精線株式会社 Guide wire for catheter
US5282781A (en) * 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US5141486B1 (en) 1990-11-05 1996-01-30 Cobe Lab Washing cells
DE69129098T2 (en) * 1990-12-18 1998-09-17 Advanced Cardiovascular System Process for producing a super-elastic guide part
US5354257A (en) * 1991-01-29 1994-10-11 Med Institute, Inc. Minimally invasive medical device for providing a radiation treatment
US5395300A (en) * 1991-06-07 1995-03-07 Omnitron International, Inc. High dosage radioactive source
CA2068584C (en) * 1991-06-18 1997-04-22 Paul H. Burmeister Intravascular guide wire and method for manufacture thereof
US5302168A (en) 1991-09-05 1994-04-12 Hess Robert L Method and apparatus for restenosis treatment
WO1993004735A1 (en) * 1991-09-05 1993-03-18 Cedars-Sinai Medical Center Method and apparatus for restenosis treatment
US5234002A (en) * 1991-10-11 1993-08-10 Advanced Cardiovascular Systems, Inc. Catheter exchange system
US5257451A (en) * 1991-11-08 1993-11-02 Ep Technologies, Inc. Method of making durable sleeve for enclosing a bendable electrode tip assembly
DE69307873T2 (en) * 1992-04-10 1997-08-07 Cardiorhythm HEART CATHETER FOR MEASURING A REFERENCE POTENTIAL
US5275597A (en) * 1992-05-18 1994-01-04 Baxter International Inc. Percutaneous transluminal catheter and transmitter therefor
EP0695204A4 (en) * 1993-04-13 1996-08-28 Mallinckrodt Medical Inc Radioactive source introduction device
US5368048A (en) * 1993-04-19 1994-11-29 Stoy; George P. Method of making radio-opaque tipped, sleeved guidewire and product
WO1994025106A1 (en) * 1993-05-04 1994-11-10 Omnitron International Incorporated Radioactive source wire, apparatus and treatment methods
US5454794A (en) * 1993-10-15 1995-10-03 Pdt Systems, Inc. Steerable light diffusing catheter
US5503613A (en) 1994-01-21 1996-04-02 The Trustees Of Columbia University In The City Of New York Apparatus and method to reduce restenosis after arterial intervention
US5503614A (en) * 1994-06-08 1996-04-02 Liprie; Samuel F. Flexible source wire for radiation treatment of diseases
US5857956A (en) 1994-06-08 1999-01-12 United States Surgical Corporation Flexible source wire for localized internal irradiation of tissue
US5622184A (en) * 1994-11-29 1997-04-22 Applied Medical Resources Corporation Guidewire and method of manufacture
US5833593A (en) 1995-11-09 1998-11-10 United States Surgical Corporation Flexible source wire for localized internal irradiation of tissue
NL1002044C2 (en) 1996-01-08 1997-07-09 Optische Ind De Oude Delft Nv Radioactive source that has clinically relevant beta radiation
US5871436A (en) 1996-07-19 1999-02-16 Advanced Cardiovascular Systems, Inc. Radiation therapy method and device
US5782741A (en) 1996-11-12 1998-07-21 Guidant Coropration Two-stage treatment wire
US5873811A (en) 1997-01-10 1999-02-23 Sci-Med Life Systems Composition containing a radioactive component for treatment of vessel wall
US5925353A (en) 1997-04-01 1999-07-20 Set Ltd Targeted radioimmunotherapy

Also Published As

Publication number Publication date
CA2222149A1 (en) 1996-12-19
EP0954351A4 (en) 2002-11-13
AU696822B2 (en) 1998-09-17
US6505392B1 (en) 2003-01-14
EP0954351A1 (en) 1999-11-10
US5857956A (en) 1999-01-12
WO1996040352A1 (en) 1996-12-19
US6876712B1 (en) 2005-04-05
JP2001517096A (en) 2001-10-02

Similar Documents

Publication Publication Date Title
US5857956A (en) Flexible source wire for localized internal irradiation of tissue
US5833593A (en) Flexible source wire for localized internal irradiation of tissue
AU695062B2 (en) Flexible source wire for radiation treatment
US6200258B1 (en) Radioactive therapeutic seed having selective marker configuration
US5575749A (en) Ultra-thin high dose radioactive source wire
US6712752B2 (en) Radioactive therapeutic seed having selective marker configuration
US5624372A (en) Source wire for localized internal irradiation of tissue
AU731357B2 (en) Combination radioactive and temperature self-regulating thermal seed implant for treating tumors
US6146322A (en) Irradiating filament and method of making same
JP2002320684A (en) Capsuled seed
JP2003504126A (en) Radioactive source train
US6666812B2 (en) Radioactive therapeutic seeds
EP2083919A1 (en) Thulium-based capsule and devices for use in high dose rate brachytherapy
AU752979B2 (en) Improved flexible source wire for localized internal irradiation of tissue
US20010055359A1 (en) Flexible source wire for radiation
AU7139600A (en) Integral capsule sourcewire and method of making

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: INTERVENTIONAL THERAPIES, L.L.C.

Free format text: FORMER OWNER WAS: ANGIORAD, L.L.C.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired